Orexigen obesity med faces uphill fight--and that's if it's approved


If Orexigen wins FDA approval for its new weight loss drug, how will it and its pharma partner Takeda take on the obesity market? After all, it's an area where two recent debuts are struggling for recognition. Report

Filed Under